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1. Introduction 
Tyrosine aminotransferase (TAT) (EC 2.6.1.5) can 
be induced in rat liver by glucagon or N6,O2'-dibutyryl 
cyclic AMP (DBcAMP) [1-3] .  The response of the 
enzyme to DBcAMP, as well as the enzyme itself, is 
under the control of glucocorticoids and other factors 
[4]. It is also known that the enzyme in CUltured 
hepatoma cells usually has a lower response to 
DBcAMP than that in rat liver in vivo [5,6]. Granner 
[7] has recently reported that TAT in HTC cells, 
otherwise ntirely insensitive to DBcAMP, becomes 
responsive to the inducer after elevating TAT level b:y 
the treatment of cells with dexamethasone (Dex)~We 
also observed that the low response of TAT in an 
established rat liver cell line (RLC) to DBcAMP can 
considerably be restored by Dex at a non-inducing 
concentration (0.1 nM) [8]. 
In this report we present the evidences showing 
that TAT in regenerating liver of adrenalectomized 
rats after partial hepatectomy totally loses its response 
to the induction by DBcAMP in vivo as well as in 
vitro in liver slices and that the addition of a non- 
inducing amount of glucocorticoids partially restores 
the response. Furthermore, it was demonstrated that 
the loss of the response isassociated with a marked 
decrease in the cyclic AMP-binding activity in cytosol. 
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saline as p(eviously described [4]. Chow was replaced 
by a lox~-protein diet (protein content < 1%) 24 h 
prior to the experiments. Partial hepatectomy was 
carried out by the method of Higgins and Anderson 
[9] with removal of 70% of the liver. Cortisone acetate 
(Ciba AG, Wehr/Baden) and DBcAMP (Boehringer 
Mannheim GmbH, Mannheim) were injected intra- 
peritoneally. Fractionation of liver for TAT determi- 
nation was carried out as previously described [4]. 
2.2. In vitro TAT induction in liver slices 
For the preparation of slices livers from 3 adrena- 
lectomized rats before and 18 h after partial hepa- 
tectomy were sliced by hand with a razor at room 
temperature. Approximately 100 mg slices were 
placed in 3 flasks each containing 6 ml Eagle's basal 
medium supplemented with 2 mM glutamine and 
DBcAMP at concentrations indicated. The flasks were 
incubated at 37°C for 3 h in an atmosphere of 95% 
02 and 5% CO2 with constant shaking. At the end of 
incubation the slices were washed 3 times with cold 
saline solution and homogenized in 3 ml cold buffer 
in a Potter type homogenizer aspreviously described 
[4]. TAT and protein were assayed on the 10 000 X g 
supernatants by the method of Diamondstone modi- 
fied by Granner and Tomkins [ 10] and Lowry [ 11 ], 
respectively. 
2. Materials and methods 
2.1. Treatments of  animals 
Female Wistar rats weighing 120-150 g were 
adrenalectomized 5-7  days prior to experiments and 
maintained on a laboratory chow and physiological 
2.3. Assay for cyclic AMP binding activity 
Cytosols were prepared by homogenizing the livers 
in 0.02 M potassium phosphate buffer, pH 7.4, con- 
taining 0.15 M KC1 in a Potter type homogenizer fol- 
lowed by centrifugation at 105 000 X g for 90 rnin. 
The binding assay was performed on the dialyzed 
cytosols by the method of Walton and Garren [12] 
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in the presence of 5.2 × 10 -5 M cyclic [3H]AMP 
(The Radiochemical Centre, Amersham). 
3. Results and discussion 
The in vivo results presented in riga show that 
DBcAMP enhances TAT activity 200% over the saline- 
treated control evel in intact (not adrenalectomized) 
rats in 3 h (A-l). Partial hepatectomy itself results in 
a striking increase in the activity probably due to an 
elevated plasma glucocorticoid level caused by the 
surgical stress [13] (A-2). Administration of DBcAMP 
to the intact rats after partial hepatectomy exerts no 
additional effect on the enzyme activity. In contrast, 
DBcAMP elevates TAT level only 60% in the adrena- 
lectomized rats is consistent with the previous report 
[4] (B-I). After partial hepatectomy TAT in the liver 
of adrenalectomized rats becomes entirely insensitive 
to the DBcAMP induction, although the basal enzyme 
level remains low (B-2). Administration of a non- 
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Fig. 1. Response in vivo of TAT to DBcAMP-induction in 
regenerating liver of intact and adrenalectomized rats. 
DBcAMP (3 mg/100 g) or cortisone acetate (0.2 mg/lO0 g) 
was injected intraperitoneally tothe normal (not hepatec- 
tomized) (A-l, B-l) and the partially hepatectomized rats 
4 h after surgery (A-2, B-2) and the rats were killed 3 h later. 
(A) Intact rats; (B) adrenalectomize6 rats. (White bar) Saline; 
(hatched bar) DBcAMP (dotted bar) DBcAMP and cortis0rii~ 
acetate. Data are means ± SE for 5-6 rats. 
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Fig.2. In vitro response of TAT to DBcAMP-induction in the 
slices from normal and regenerating livers of adrenaleetomized 
rats. Slices prepared from the adrenalectomized rats before (I) 
and 18 h after hepatectomy (II) were incubated for 3 h with 
increasing concentrations ofDBcAMP and TAT was assayed 
as described under Materials and methods. Curve III is the 
same as II except hat the slices were incubated in the presence 
of 1 nM Dex. The data are the means -+ SE for 3 incubations. 
inducing dose of  cortisone acetate (0.2 mg/lO0.g) [4] 
together with DBcAMP markedly restores the response 
of TAT to the nucleotide inducer in the regenerating 
liver of  adrenalectomized rats. The loss of  the response 
of TAT to DBcAMP in regenerating liver was also 
confirmed in an in vitro system using liver slices. As 
seen in fig.2 TAT can readily be induced by DBcAMP 
in the non-regenerating liver slices from adrenalecto- 
mized rats (curve I). This increment of  the TAT 
activity may represent the glucocorticoid-independent 
fraction of the enzyme induction [4]. In marked con- 
trast, TAT cannot be induced at all by DBcAMP in the 
slices from regenerating liver of  adrenalectomized rats 
18 h after partial hepatectomy (curve II). Addition 
of a non-inducing concentration of Dex (1 nM) to the 
medium together with DBcAMP restores the response 
of the enzyme over the level of non-regenerating liver 
slices in a range of low DBcAMP concentrations 
(curve III). This restored response may represent the 
glucocorticoid-dependent induction medium by 
DBcAMP. At higher DBcAMP concentrations 
(> 1.0 mM) Dex is rather inhibitory. 
Rijn et al. [6] found no direct correlation between 
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growth rate and induction of TAT by DBcAMP in 
four different hepatoma cell lines. The result of 
Granner [7] also is indicative of the independence of
the enzyme response on the growth rate and cell cycle 
of HTC ceils. On the other hand, serine dehydratase 
was found by Kapp et al. [14] to be inducible by 
DBcAMP only in the late S-phase in CHO cells. During 
fetal and neonatal development of rats changes in the 
response of several hepatic enzymes to glucagon or 
DBcAMP have been observed [ 15-18] .  In the present 
study we found the absence of in vivo and in vitro 
response of TAT to DBcAMP from the cells in the 
prereplicative phase of the regenerating liver of adrena- 
lectomized rats. Since glucocorticoids do not affect 
the mitotic activity of regenerating liver [19], our 
present results uggest hat the loss of the glucocor- 
ticoid-independent response of TAT to DBcAMP is 
characteristic of the proliferating cells or calls ready 
to proliferate. In view of the recent finding that a 
specific cyclic AMP-binding site is deficient from 
hepatoma cells [20-23]  and that during the devel- 
opmental period of rat liver the cyclic AMP-binding 
activity changes [24], the cyclic AMP-binding protein 
was assayed on the cytosol fractions from the rege- 
nerating liver of adrenalectomized rats 18 h after 
partial hepatectomy. Figure 3 demonstrates a con- 
siderable reduction in the cyclic AMP-binding activity 
of the regenerating liver. Several binding proteins are 
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Fig.3. Cyclic AMP-binding activity as a function of protein 
concentration f cytosols from normal and regenerating livers 
of adrenalectomized rats. Cytosols were prepared from the 
livers of adrenalectomized rats before (I) and 18 h after 
partial hepatectomy (II). Cyclic AMP-binding assay was done 
on the dialyzed cytosols as described in the text. 
reported to be present in rat liver cytosol [22,25] 
and the lack of one of these proteins was shown with 
the HTC hepatoma cell line [22], which is highly 
insensitive to DBcAMP in terms of the TAT induc- 
tion. It seems likely that the lack of response of TAT 
to DBcAMP in regenerating liver is associated with 
the absence of a certain cyclic AMP-binding protein 
which is essential for the transmission of the cyclic 
AMP effect. 
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